Seres Therapeutics Inc
F:1S9

Watchlist Manager
Seres Therapeutics Inc Logo
Seres Therapeutics Inc
F:1S9
Watchlist
Price: 0.2 EUR Market Closed
Market Cap: 30.3m EUR

Wall Street
Price Targets

1S9 Price Targets Summary
Seres Therapeutics Inc

Wall Street analysts forecast 1S9 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 1S9 is 0.28 EUR with a low forecast of 0.26 EUR and a high forecast of 0.3 EUR.

Lowest
Price Target
0.26 EUR
32% Upside
Average
Price Target
0.28 EUR
40% Upside
Highest
Price Target
0.3 EUR
51% Upside
Seres Therapeutics Inc Competitors:
Price Targets
688105
Nanjing Vazyme Biotech Co Ltd
44% Upside
IPH
Innate Pharma SA
223% Upside
LXRX
Lexicon Pharmaceuticals Inc
139% Upside
RLYB
Rallybio Corp
39% Upside
VCYT
Veracyte Inc
15% Upside
KURA
Kura Oncology Inc
204% Upside
068270
Celltrion Inc
22% Upside
2142
Hbm Holdings Ltd
5% Upside

Revenue
Forecast

Revenue Estimate
Seres Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Seres Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Seres Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-70%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 1S9's stock price target?
Price Target
0.28 EUR

According to Wall Street analysts, the average 1-year price target for 1S9 is 0.28 EUR with a low forecast of 0.26 EUR and a high forecast of 0.3 EUR.

Back to Top